Nader Rifai

Author PubWeight™ 465.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003 23.97
2 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 16.23
3 Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006 15.60
4 Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007 15.32
5 Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007 9.68
6 C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005 9.47
7 Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004 7.46
8 C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 2008 7.33
9 C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003 6.99
10 Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009 6.16
11 Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol 2004 6.08
12 Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 2007 5.95
13 Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 2004 5.86
14 C-reactive protein and the risk of developing hypertension. JAMA 2003 5.75
15 Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 2005 5.74
16 C-reactive protein and the risk of incident colorectal cancer. JAMA 2004 4.94
17 Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med 2004 4.92
18 Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004 4.67
19 Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004 4.58
20 Association between C-reactive protein and age-related macular degeneration. JAMA 2004 4.16
21 Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004 4.04
22 Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009 3.93
23 Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation 2005 3.85
24 Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004 3.69
25 Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2004 3.61
26 Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr 2005 3.55
27 The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 2004 3.50
28 Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 2008 3.03
29 Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002 3.01
30 Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002 2.86
31 Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet 2008 2.85
32 Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 2002 2.84
33 Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002 2.79
34 Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 2002 2.78
35 Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA 2004 2.70
36 Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003 2.52
37 Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics 2014 2.37
38 Serum estrogen, but not testosterone, levels differ between black and white men in a nationally representative sample of Americans. J Clin Endocrinol Metab 2007 2.36
39 Low-density lipoprotein particle concentration and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation 2002 2.36
40 Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care 2007 2.33
41 Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women. Clin Chem 2009 2.31
42 High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003 2.28
43 Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women. JAMA 2006 2.27
44 Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study. Circulation 2008 2.22
45 Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women. Diabetes 2007 2.19
46 Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005 2.17
47 A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2005 2.15
48 Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 2005 2.09
49 Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 2005 2.08
50 Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 2007 2.08
51 Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002 2.06
52 A prospective study of inflammatory cytokines and diabetes mellitus in a multiethnic cohort of postmenopausal women. Arch Intern Med 2007 2.05
53 Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem 2007 2.05
54 Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation 2005 2.02
55 Lipoprotein(a) and risk of type 2 diabetes. Clin Chem 2010 2.01
56 Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med 2008 2.01
57 Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation 2004 1.99
58 Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 2008 1.95
59 CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the laboratory science discussion group. Circulation 2004 1.93
60 Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004 1.88
61 Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Eur Heart J 2008 1.88
62 Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes 2005 1.87
63 Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era. Cancer Epidemiol Biomarkers Prev 2005 1.80
64 C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. Clin Chim Acta 2002 1.78
65 Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation 2004 1.78
66 Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Circulation 2007 1.76
67 Association of markers of insulin and glucose control with subsequent colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2003 1.75
68 B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004 1.75
69 A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. J Natl Cancer Inst 2012 1.74
70 Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 2002 1.73
71 Interactions between the -514C->T polymorphism of the hepatic lipase gene and lifestyle factors in relation to HDL concentrations among US diabetic men. Am J Clin Nutr 2005 1.72
72 Consumption of (n-3) fatty acids is related to plasma biomarkers of inflammation and endothelial activation in women. J Nutr 2004 1.70
73 High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004 1.69
74 Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events. J Am Coll Cardiol 2008 1.69
75 Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies. Am J Epidemiol 2007 1.68
76 National Academy of Clinical Biochemistry Laboratory Medicine Practice guidelines: emerging biomarkers for primary prevention of cardiovascular disease. Clin Chem 2008 1.65
77 Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women. Am J Med 2003 1.62
78 Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin Chem 2002 1.59
79 Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women? J Am Coll Cardiol 2006 1.59
80 Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 2005 1.57
81 Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death. Clin Chem 2008 1.56
82 Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 2003 1.56
83 Identifying duplicate publications: primum non nocere. Clin Chem 2008 1.55
84 Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care 2004 1.53
85 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chim Acta 2012 1.51
86 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Transfusion 2012 1.50
87 Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003 1.49
88 Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation 2006 1.48
89 Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study. Circulation 2011 1.47
90 E-selectin genotypes and risk of type 2 diabetes in women. Obes Res 2005 1.46
91 Commercial immunoassays in biomarkers studies: researchers beware! Clin Chem Lab Med 2013 1.44
92 Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control 2009 1.43
93 C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem 2003 1.42
94 A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem 2009 1.41
95 The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005 1.38
96 Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2011 1.37
97 A girl with goiter and inappropriate thyroid-stimulating hormone secretion. Clin Chem 2008 1.36
98 Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 2005 1.36
99 Symptomatic peripheral arterial disease in women: nontraditional biomarkers of elevated risk. Circulation 2008 1.34
100 Multiple biomarkers and the risk of incident hypertension. Hypertension 2007 1.34
101 Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res 2003 1.34
102 Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988-1994 and 1999-2000 National Health and Nutrition Examination Surveys. Clin Chem 2006 1.34
103 C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care 2004 1.33
104 Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol 2012 1.32
105 Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. J Am Coll Cardiol 2005 1.31
106 Moderate alcohol consumption and lower levels of inflammatory markers in US men and women. Atherosclerosis 2005 1.30
107 Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 2003 1.29
108 C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women. Cancer Epidemiol Biomarkers Prev 2006 1.27
109 Effects of initiating insulin and metformin on glycemic control and inflammatory biomarkers among patients with type 2 diabetes: the LANCET randomized trial. JAMA 2009 1.27
110 Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes Control 2008 1.26
111 Inflammation and progressive nephropathy in type 1 diabetes in the diabetes control and complications trial. Diabetes Care 2008 1.25
112 Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 2003 1.25
113 Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. Diabetes Care 2002 1.25
114 Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care 2004 1.24
115 Body iron stores and their determinants in healthy postmenopausal US women. Am J Clin Nutr 2003 1.22
116 D-dimer, inflammatory markers, and lower extremity functioning in patients with and without peripheral arterial disease. Circulation 2003 1.22
117 Sex steroid hormone concentrations and risk of death in US men. Am J Epidemiol 2010 1.22
118 Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trial. Eur J Endocrinol 2012 1.21
119 C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol 2007 1.21
120 Body fatness and sex steroid hormone concentrations in US men: results from NHANES III. Cancer Causes Control 2011 1.21
121 Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res 2013 1.20
122 Soluble intercellular adhesion molecules, soluble vascular cell adhesion molecules, and risk of coronary heart disease. Obesity (Silver Spring) 2006 1.19
123 Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III). Urology 2007 1.17
124 D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2005 1.16
125 Fructose, glycemic load, and quantity and quality of carbohydrate in relation to plasma C-peptide concentrations in US women. Am J Clin Nutr 2004 1.15
126 Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial. Hypertension 2006 1.15
127 Stability of measurements of biomarkers of oxidative stress in blood over 36 hours. Cancer Epidemiol Biomarkers Prev 2004 1.14
128 Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 2009 1.13
129 Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005 1.13
130 Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts. Cancer Res 2007 1.13
131 Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc 2013 1.11
132 Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis 2011 1.11
133 Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J Am Coll Cardiol 2009 1.11
134 Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial. Eur Heart J 2010 1.10
135 High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol 2007 1.10
136 Elevated levels of inflammation, d-dimer, and homocysteine are associated with adverse calf muscle characteristics and reduced calf strength in peripheral arterial disease. J Am Coll Cardiol 2007 1.09
137 Alcohol consumption patterns and HbA1c, C-peptide and insulin concentrations in men. J Am Coll Nutr 2003 1.08
138 Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes. J Nutr 2009 1.08
139 Cardiac troponin increases among runners in the Boston Marathon. Ann Emerg Med 2006 1.08
140 Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Circulation 2006 1.07
141 Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men. Am J Epidemiol 2007 1.06
142 Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis 2006 1.05
143 HFE genetic variability, body iron stores, and the risk of type 2 diabetes in U.S. women. Diabetes 2005 1.05
144 Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation 2004 1.04
145 Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial. Cancer Prev Res (Phila) 2013 1.04
146 C-reactive protein and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 2008 1.03
147 Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2011 1.02
148 Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol Biomarkers Prev 2009 1.02
149 Circulating levels of resistin and risk of type 2 diabetes in men and women: results from two prospective cohorts. Diabetes Care 2008 1.01
150 Interleukin-6 receptor gene, plasma C-reactive protein, and diabetes risk in women. Diabetes 2008 1.01
151 Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women. J Natl Cancer Inst 2005 1.01
152 Prediagnosis biomarkers of insulin-like growth factor-1, insulin, and interleukin-6 dysregulation and multiple myeloma risk in the Multiple Myeloma Cohort Consortium. Blood 2012 1.01
153 Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol 2004 1.01
154 Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin Endocrinol (Oxf) 2008 1.00
155 Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study. Am J Hypertens 2005 1.00
156 Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev 2013 0.99
157 Reporting bias in diagnostic and prognostic studies: time for action. Clin Chem 2008 0.99
158 Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies. Cancer Causes Control 2010 0.99
159 Excessive body iron stores are not associated with risk of coronary heart disease in women. J Nutr 2008 0.98
160 Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clin Chem 2007 0.97
161 Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. Arterioscler Thromb Vasc Biol 2007 0.97
162 Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. Circulation 2007 0.97
163 A cross-sectional study of alcohol consumption patterns and biologic markers of glycemic control among 459 women. Diabetes Care 2003 0.96
164 No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer. Prostate 2004 0.96
165 A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab 2008 0.95
166 Functional decline in patients with and without peripheral arterial disease: predictive value of annual changes in levels of C-reactive protein and D-dimer. J Gerontol A Biol Sci Med Sci 2006 0.95
167 Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22). Am J Cardiol 2006 0.94
168 Biomarker discovery and validation. Clin Chem 2006 0.94
169 Circulating blood markers and functional impairment in peripheral arterial disease. J Am Geriatr Soc 2008 0.94
170 What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema. Scand J Clin Lab Invest Suppl 2010 0.93
171 The prevalence of low sex steroid hormone concentrations in men in the Third National Health and Nutrition Examination Survey (NHANES III). Clin Endocrinol (Oxf) 2011 0.93
172 Interleukin-6 receptor gene variations, plasma interleukin-6 levels, and type 2 diabetes in U.S. Women. Diabetes 2007 0.93
173 Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier? Eur Heart J 2005 0.93
174 Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. Clin Chem 2007 0.92
175 Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men. Clin Endocrinol (Oxf) 2008 0.92
176 Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns. Am J Cardiol 2008 0.91
177 Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials. Clin Chem 2003 0.91
178 Expanding options for scientific publication: is more always better? Circulation 2013 0.90
179 Circulating adipocytokines and chronic kidney disease. PLoS One 2013 0.89
180 A prospective study of hemoglobin A1c concentrations and risk of breast cancer in women. Cancer Res 2006 0.89
181 Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. Obes Res 2005 0.88
182 Plasma adrenal androgens and risk of breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev 2004 0.88
183 C-reactive protein and cardiovascular risk in the Framingham Study. Arch Intern Med 2006 0.88
184 Interleukin-18 and the risk of future cardiovascular disease among initially healthy women. Atherosclerosis 2008 0.87
185 Serum cardiac troponin and subclinical cardiac status in pediatric chronic renal failure. Pediatrics 2003 0.87
186 Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am Heart J 2011 0.87
187 Intercellular adhesion molecule 1 (ICAM1) Lys56Met and Gly241Arg gene variants, plasma-soluble ICAM1 concentrations, and risk of incident cardiovascular events in 23,014 initially healthy white women. Stroke 2007 0.86
188 How to use C-reactive protein in acute coronary care. Eur Heart J 2013 0.86
189 Inflammatory plasma markers and pancreatic cancer risk: a prospective study of five U.S. cohorts. Cancer Epidemiol Biomarkers Prev 2013 0.86
190 Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. Eur Heart J 2007 0.86
191 Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia. Am J Cardiol 2002 0.86
192 Evaluation of the AccuTnI cardiac troponin I assay for risk assessment in acute coronary syndromes. Clin Chem 2003 0.85
193 Rapid and simple tandem mass spectrometry method for determination of serum cotinine concentration. Clin Chem 2004 0.85
194 Plasma dehydroepiandrosterone and risk of myocardial infarction in women. Clin Chem 2008 0.84
195 Comparative analysis of zinc protoporphyrin and blood lead levels in lead-exposed Andean children. Clin Biochem 2007 0.84
196 Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial. Eur Heart J 2003 0.84
197 Association of C-reactive protein and serum amyloid A with recurrent coronary events in stable patients after healing of acute myocardial infarction. Am J Cardiol 2002 0.84
198 Racial variation in umbilical cord blood leptin concentration in male babies. Cancer Epidemiol Biomarkers Prev 2011 0.84
199 Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women. Clin Chem 2013 0.84
200 Impact of the third cholesterol report from the adult treatment panel of the national cholesterol education program on the clinical laboratory. Clin Chem 2002 0.84
201 Association between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study. Cancer Prev Res (Phila) 2010 0.84
202 Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study. Am J Hypertens 2004 0.83
203 Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III). Aging Male 2012 0.83
204 Frequency of clinically unsuspected myocardial injury at a children's hospital. Am Heart J 2006 0.83
205 Elevated plasma levels of endostatin are associated with chronic kidney disease. Am J Nephrol 2012 0.83
206 Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among U.S. diabetic men. Diabetes 2006 0.82
207 Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women. Clin Chem 2011 0.82
208 Racial variation in vitamin D cord blood concentration in white and black male neonates. Cancer Causes Control 2012 0.82
209 Commercial immunoassays in biomarkers studies: researchers beware! Clin Chem 2012 0.82
210 Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. Am Heart J 2012 0.82
211 Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK&F 95654 in the spontaneously hypertensive rat. Toxicol Pathol 2006 0.82
212 Racial variation in umbilical cord blood sex steroid hormones and the insulin-like growth factor axis in African-American and white female neonates. Cancer Causes Control 2012 0.81
213 The association of urinary cadmium with sex steroid hormone concentrations in a general population sample of US adult men. BMC Public Health 2008 0.81
214 The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies. J Am Coll Cardiol 2002 0.81
215 Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. Cancer Causes Control 2012 0.80
216 Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Thromb Thrombolysis 2012 0.80
217 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem Lab Med 2012 0.80
218 Nonfasting low-density lipoprotein testing: utility for cholesterol screening in pediatric primary care. Clin Pediatr (Phila) 2007 0.80
219 Inhibition of the renin-angiotensin system reduces the rise in serum aldosterone in acute coronary syndrome patients with preserved left ventricular function: observations from the AVANT GARDE-TIMI 43 trial. Clin Chem 2013 0.79
220 A multiplex immunoassay gives different results than singleplex immunoassays which may bias epidemiologic associations. Clin Biochem 2012 0.79
221 Plasma adiponectin and the risk of hypertension in white and black postmenopausal women. Clin Chem 2012 0.79
222 High-sensitivity C-reactive protein and cardiovascular disease. Clin Chem 2008 0.79
223 Alcohol consumption and high-density lipoprotein levels: the effect of ADH1C genotype, gender and menopausal status. Atherosclerosis 2005 0.79
224 Serum cardiac troponin T as a biomarker for acute myocardial injury induced by low doses of isoproterenol in rats. Cardiovasc Toxicol 2006 0.79
225 Association between sex steroid hormones and hematocrit in a nationally representative sample of men. J Androl 2012 0.78
226 A message from the laboratory community to the National Cholesterol Education Program Adult Treatment Panel IV. Clin Chem 2012 0.78
227 The riddle of protein diagnostics: future bleak or bright? Clin Chem 2012 0.78
228 Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study. Atherosclerosis 2009 0.78
229 Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16. J Thromb Thrombolysis 2007 0.78
230 Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients. Am J Cardiol 2003 0.78
231 Early dynamic risk stratification with baseline troponin levels and 90-minute ST-segment resolution to predict 30-day cardiovascular mortality in ST-segment elevation myocardial infarction: analysis from CLopidogrel as Adjunctive ReperfusIon TherapY (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28. Am Heart J 2010 0.78
232 High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci 2002 0.78
233 Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III. Cancer Causes Control 2010 0.77
234 Frequent intake of tropical fruits that are rich in beta-cryptoxanthin is associated with higher plasma beta-cryptoxanthin concentrations in Costa Rican adolescents. J Nutr 2002 0.77
235 Association between endogenous sex steroid hormones and insulin-like growth factor proteins in US men. Cancer Causes Control 2014 0.77
236 Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Am J Cardiol 2006 0.77
237 No effect of beta-carotene supplementation on risk of nonmelanoma skin cancer among men with low baseline plasma beta-carotene. Cancer Epidemiol Biomarkers Prev 2004 0.76
238 Declining blood lead and zinc protoporphyrin levels in Ecuadorian Andean children. Clin Biochem 2013 0.76
239 Publication ethics: clinical chemistry editorial standards. Clin Chem 2008 0.76
240 Association of resistin promoter polymorphisms with plasma resistin levels and type 2 diabetes in women and men. Int J Mol Epidemiol Genet 2010 0.76
241 Statistical methods for test and biomarker evaluation studies: a clinical chemistry series. Clin Chem 2012 0.76
242 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Scand J Clin Lab Invest 2012 0.75
243 Evaluation of an enzymatic homocysteine assay for the Hitachi series chemistry analyzer. Clin Chim Acta 2005 0.75
244 Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Ann Clin Biochem 2011 0.75
245 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chem 2012 0.75
246 Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Clin Chem Lab Med 2010 0.75
247 Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Scand J Clin Lab Invest 2010 0.75
248 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Am J Hematol 2012 0.75
249 Full-disclosure in industry-sponsored laboratory medicine research studies: Statement by the Consortium of Laboratory Medicine Journal Editors. Am J Hematol 2011 0.75
250 Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Clin Chim Acta 2010 0.75
251 Measurement of whole blood sirolimus by an HPLC assay using solid-phase extraction and UV detection. Ther Drug Monit 2002 0.75
252 An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Biochem 2012 0.75
253 International Year of Chemistry 2011: Clinical Chemistry celebrates. Clin Chem 2010 0.75
254 Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Transfusion 2010 0.75
255 Colloquium on rethinking the future of scientific communication. Clin Chem 2012 0.75
256 Normal homocysteine levels in a population of children with inflammatory bowel disease. Inflamm Bowel Dis 2005 0.75
257 Full disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors. Clin Chem 2010 0.75
258 Preparation of manuscripts for publication: improving your chances for success. Clin Chem 2009 0.75
259 Standardization of high-sensitivity immunoassays for measurement of C-reactive protein; II: Two approaches for assessing commutability of a reference material. Clin Chem 2008 0.75